There is no need to take the same drugs such as Ozempic for weight loss.

Those who take GLP-1 drugs, such as Ozempic, can lose weight even if they stop approaching the drug, which can reassure the user when there is a lack of treatment.

Drugs, such as Semaglutide, also known as the Ozempic and WEGOVY brand names, have changed how to treat obesity, but when demand increases, there is a lack of supply. In the United States, if a health insurance company changes its drugs, it can cause confusion. For example, CVS CARREMARK, which helps insurers manage prescription plans. Recently, I covered Ellie Lily’s ZepboundThis is based on GLP-1 drug Tirzepatide.

To explore the influence of such confusion Kaelen Medeiros And her colleagues in New York’s Calibrate, who are headquartered in New York, offer drugs and digital support that offers drugs and digital support to help people lose weight. In 2021 and 2024, we analyzed more than 6,000 data in the United States to register for the company’s program for one year. Nearly 90 %of the participants were overweight with obesity, with weights such as high cholesterol or wolesterol.

This program was able to access an app that provides classes every two weeks on how to optimize lifestyle habits such as exercise and exercise. Also, every few weeks they got a one -on -one chat with a health coach and helped to implement this lesson. For additional charges, all participants are mainly GLP-1 drugs such as Ozempic.

At the end of the program, 73 %of the participants experienced at least one stop in the GLP-1 approach, which was defined at least 13 weeks without drugs. These participants received an average eight-month GLP-1 supply in a one-year trial. Individuals still lost 14 %of the weight. The results were announced on July 14 at the annual meeting of the endocrine association in San Francisco, California.

In the second year of the program, a similar weight loss rate occurred among those who had a consecutive GLP-1 drug supply. Medeiros said, “I am happy to find that the interruption will be better, but despite confusion, I can find that I can achieve a significant weight loss.

“This study is relieved Priya jaisinghani At NYU LANGONE HEALTH in New York. But further research should explore the weight loss impact of the health coaching and lifestyle classes received by participants, she says. Researchers did not measure how well each group was involved in this part of this program. Medeiros says that the difference in compliance can affect the results.

Medeiros says some of the participants have taken metformin, a type 2 diabetes drug that can contribute to weight loss, and Medeiros says. But metformin is connected Only about 2 % of the weight is lost.